培训课件--NCCN指南变迁解读.pptxVIP

2016 NCCN Guidelines Acute Myeloid Leukemia NCCN AML 2016 V1 目录 AML-1 / EVALUATION FOR ACUTE LEUKEMIA AML-2 / APL CLASSIFICATION AML-3 / TREATMENT INDUCTION (HIGH RISK) AML-4 / TREATMENT INDUCTION (LOW RISK) AML-5 / APL POST-CONSOLIDATION MONITORING AML-6 / APL-THERAPY FOR RELAPSE AML-7/ AML CLASSIFICATION AML-8 / AML POST-INDUCTION THERAPY AFTER STANDARD-DOSE CYTARABINE, 60y AML-9 / AML POST-INDUCTION THERAPY AFTER HIGH-DOSE CYTARABINE, 60y AML-10 / POST-REMISSION THERAPY, 60y AML-11 / AML ≥ 60y AML-12 / AML POST-INDUCTION THERAPY AFTER STANDARD-DOSE CYTARABINE, ≥ 60y AML-13 / POST-REMISSION